학술논문
'학술논문'
에서 검색결과 52건 | 목록
1~10
Academic Journal
Pires da Silva I; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Faculty of Medicine & Health, The University of Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, NSW, Australia; Crown Princess Mary Cancer Centre Westmead, Blacktown Hospital, Sydney, Australia. Electronic address: ines.silva@melanoma.org.au.; Li I; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia.; Ugurel S; Department of Dermatology, University Hospital Essen, and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen, Germany.; Serra-Bellver P; The Christie NHS Foundation Trust, Manchester, UK.; Andhale A; The Christie NHS Foundation Trust, Manchester, UK.; Burnette H; Vanderbilt University Medical Center, Nashville, TN, United States.; Aya F; Department of Medical Oncology, IDIBAPS, Hospital Clínic, Barcelona, Spain.; Conway JW; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Faculty of Medicine & Health, The University of Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, NSW, Australia.; Braden J; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Faculty of Medicine & Health, The University of Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, NSW, Australia.; Carlino MS; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Crown Princess Mary Cancer Centre Westmead, Blacktown Hospital, Sydney, Australia.; Menzies AM; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Faculty of Medicine & Health, The University of Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia.; Weichenthal M; University Skin Cancer Center Kiel, University Hospital of Schleswig-Holstein, Kiel, Germany.; Mohr P; Elbe-Klinikum Buxtehude, Buxtehude, Germany.; Gutzmer R; Ruhr University Bochum Campus Minden, Minden, Germany.; Arance AM; Department of Medical Oncology, IDIBAPS, Hospital Clínic, Barcelona, Spain.; Johnson DB; Vanderbilt University Medical Center, Nashville, TN, United States.; Lorigan P; The Christie NHS Foundation Trust, Manchester, UK.; Schadendorf D; Department of Dermatology, University Hospital Essen, and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen, Germany; Westdeutsches Tumorzentrum (WTZ) & National Center for Tumor Diseases (NCT-West), Campus Essen & University Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany.; Lo SN; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Faculty of Medicine & Health, The University of Sydney, NSW, Australia.; Long GV; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Faculty of Medicine & Health, The University of Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia. Electronic address: ines.silva@melanoma.org.au.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Mandalà M; Unit of Medical Oncology, University of Perugia, Perugia, Italy. Electronic address: mario.mandala@unipg.it.; Lorigan P; The University of Manchester, Oxford Rd, Manchester M13 9PL, UK.; Sergi MC; Medical Oncology Unit, Azienda Ospedaliero Universitaria Policlinico di Bari, Bari, Italy.; Benannoune N; Gustave Roussy Cancer Campus, Villejuif, France.; Serra P; The University of Manchester, Oxford Rd, Manchester M13 9PL, UK.; Vitale MG; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy.; Giannarelli D; Epidemiology and Biostatistics, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy.; Arance AM; Hospital Clínic Barcelona, 08036 Barcelona, Spain.; Couselo EM; Department of Medical Oncology. Vall d'Hebron Hospital, Barcelona, Spain & Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Neyns B; Department of Medical Oncology, UZ Brussel, Brussels, Belgium.; Tucci M; Medical Oncology Unit, Azienda Ospedaliero Universitaria Policlinico di Bari, Bari, Italy.; Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori 'Giovanni Paolo II,' Bari, Italy.; Spagnolo F; IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy.; Rossi E; Medical Oncology, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy.; Occelli M; Medical Oncology, AO S.Croce e Carle, Cuneo, Italy.; Queirolo P; IEO European Institute of Oncology, IRCCS, Milan, Italy.; Quaglino P; Department of Dermatology, University of Turin, Turin, Italy.; Depenni R; University of Modena and Reggio Emilia, Department of Oncology, Hematology, Modena, Emilia-Romagna, Italy.; Merelli B; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.; Placzke J; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.; Del Vecchio M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Indini A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; da Silva IP; Melanoma Institute Australia, University of Sydney, and Blacktown Hospital, Sydney, New South Wales, Australia.; Menzies AM; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Long GV; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia.; Robert C; Gustave Roussy and Paris-Saclay University, Villejuif, France.; Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Bratland Å; Head and Neck Oncology, Oslo University Hospital, Sognsvannsveien 20, 0372, Oslo, Norway. brt@ous-hf.no.; Munoz-Couselo E; Department of Medical Oncology, Melanoma and Other Skin Tumors Unit, Vall d'Hebron Hospital, Passeig de la Vall d'Hebron, 119, 08035, Barcelona, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Passeig de la Vall d'Hebron, 119, 08035, Barcelona, Spain.; Mortier L; Department of Dermatology, INSERM U 1189, Université Lille, Centre Hospitalier Regional Universitaire de Lille, 2, Avenue Oscar Lambret, 59037, Lille, France.; Roshdy O; Division of Dermatology, McGill University, 845 Sherbrooke St W, Montreal, QC, H3A 0G4, Canada.; González R; Surgical Oncology, Centro Estatal de Cancerologiade Chihuahua, C. Ejercito Mexicano 3700, 31000, Chihuahua, Mexico.; Schachter J; Division of Oncology, Level 2, Cancer Center (Oncology Institute), Sheba Medical Center-Tel Hashomer, Emek HaEla Street 1, 52621, Ramat Gan, Israel.; Arance AM; Medical Oncology, Hospital Clinic de Barcelona, Carrer de Villarroel, 170, 08036, Barcelona, Spain.; Grange F; Dermatology/Oncology, CHU Reims-Hôpital Robert Debre, Avenue du General Koenig Service de Dermatologie, 51100, Reims, France.; Dermatology Department, Valence Hospital, 179 Bd Maréchal Juin, 26000, Valence, France.; Meyer N; Onco-Dermatology, Institut Claudius Regaud, Institut Universitaire du Cancer and CHU, 1 Avenue Irene Joliot Curie, 31059, Toulouse, France.; Joshi AJ; Department of Medical Oncology, Townsville University Hospital, 55 Keane Street, Douglas, QLD, 4814, Australia.; Billan S; Head and Neck Malignancies Unit, Rambam Health Care Campus, Technion-Israel Institute of Technology, HaAliya HaShniya St 8, 52621, Haifa, Israel.; Hughes BGM; Oncology, Clinical Research Unit, Medical Oncology, Royal Brisbane and Women's Hospital, Butterfield Street, Ground Floor, Building 34, Herston, QLD, 4029, Australia.; Department of Oncology, University of Queensland, 308 Queen St, Brisbane, QLD, 4000, Australia.; Grob JJ; Dermatology, AIX-Marseille University and APHM Hospital Marseille, 264 Rue Saint Pierre, 13385, Marseille, France.; Ramakrishnan K; Medical Oncology, Merck & Co., Inc., 2025 E Scott Ave, Rahway, NJ, 07065, USA.; Ge J; Medical Oncology, Merck & Co., Inc., 2025 E Scott Ave, Rahway, NJ, 07065, USA.; Gumuscu B; Medical Oncology, Merck & Co., Inc., 2025 E Scott Ave, Rahway, NJ, 07065, USA.; Swaby RF; Medical Oncology, Merck & Co., Inc., 2025 E Scott Ave, Rahway, NJ, 07065, USA.; Gutzmer R; Department of Dermatology, Skin Cancer Center Hannover, Hannover Medical School, Carl-Neuberg-Str. 1, 60325, Hannover, Germany.; Department of Dermatology, Johannes Wesling Medical Center Hans-Nolte-Straße 1, 32429, Minden, Germany.; Ruhr University Bochum, Universitätsstraße 150, 44801, Bochum, Germany.
Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) Subsets: PubMed not MEDLINE
Conference
Ascierto, PA; Mandala, M; Ferrucci, PF; Guidoboni, M; Rutkowski, P; Ferraresi, V; Arance, AM; Guida, M; Maiello, E; Gogas, H; Richtig, E; Fierro, MT; Lebbe, C; Helgadottir, H; Bermejo, IM; Palmieri, G; Giannarelli, D; Grimaldi, AM; Dummer, R; Chiarion-Sileni, V
JOURNAL OF CLINICAL ONCOLOGY. 40(16)
Academic Journal
Serra-Bellver P; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom. Electronic address: p.serra@nhs.net.; Versluis JM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oberoi HK; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Zhou C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, United Kingdom.; Slattery TD; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Khan Y; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Patrinely JR; Department of Medical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.; Pires da Silva I; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Westmead and Blacktown Hospital, Sydney, Australia.; Martínez-Vila C; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Cook N; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom.; Graham DM; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom.; Carlino MS; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Westmead and Blacktown Hospital, Sydney, Australia.; Menzies AM; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia.; Arance AM; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Johnson DB; Department of Medical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.; Long GV; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia.; Pickering L; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Larkin JMG; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom.; Blank CU; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Lorigan P; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Larkin J; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: James.Larkin@rmh.nhs.uk.; Weber J; Department of Medical Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Del Vecchio M; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Gogas H; Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Arance AM; Department of Medical Oncology, Hospital Clínic de Barcelona-IDIBAPS, Barcelona, Spain.; Dalle S; Department of Dermatology, Hospices Civils de Lyon, Pierre Bénite, France.; Cowey CL; Department of Medical Oncology, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA.; Schenker M; Department of Medical Oncology Oncology Center Sf Nectarie, Craiova, Romania.; Grob JJ; Department of Dermatology, Aix-Marseille University, Hôpital de La Timone, Marseille, France.; Chiarion-Sileni V; Melanoma Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.; Márquez-Rodas I; Department of Medical Oncology, General University Hospital Gregorio Marañón and CIBERONC, Madrid, Spain.; Butler MO; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.; Middleton MR; Department of Oncology, Churchill Hospital, Oxford, UK.; De la Cruz-Merino L; Department of Clinical Oncology, Hospital University Virgen Macarena, Seville, Spain.; Arenberger P; Department of Dermatology, Charles University Third Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic.; Atkinson V; Division of Cancer Services, Gallipoli Medical Research Foundation, University of Queensland, Brisbane, QLD, Australia.; Hill A; Department of Medical Oncology, Tasman Health Care, Southport, QLD, Australia.; Fecher LA; Department of Internal Medicine, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.; Millward M; Department of Internal Medicine, University of Western Australia and Sir Charles Gairdner Hospital, Nedlands, WA, Australia.; Khushalani NI; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.; Queirolo P; Medical Oncology of Melanoma, Sarcoma and Rare Tumors, IEO European Institute of Oncology IRCCS, Milan, Italy.; Long GV; Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.; Lobo M; Oncology Clinical Development, Bristol Myers Squibb, Princeton, NJ, USA.; Askelson M; Oncology Clinical Development, Bristol Myers Squibb, Princeton, NJ, USA.; Ascierto PA; Melanoma Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Mandalá M; Oncology Unit, University of Perugia, Perugia, Italy.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Rojas-Lechuga MJ; Otorhinolaryngology Department, Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Gras-Cabrerizo JR; Otorhinolaryngology Head-Neck Surgery Department, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain.; Aviles-Jurado FX; Otorhinolaryngology Department, Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Head Neck Clínic, University and Research Grants Management Agency (AGAUR), 2017-SGR-01581.; and Center for Biomedical Research Network on Diabetes and Metabolic Diseases (CIBERDEM), Barcelona, Spain.; Malvehy J; Melanoma Unit, Department of Dermatology, Hospital Clinic de Barcelona, IDIBAPS, Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain.; Arance AM; Oncology Department, Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain.; Castillo P; Pathology Department, Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain.; Barreiro A; Melanoma Unit, Department of Dermatology, Hospital Clinic de Barcelona, IDIBAPS, Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain.; Podlipnik S; Melanoma Unit, Department of Dermatology, Hospital Clinic de Barcelona, IDIBAPS, Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain.; Lopez-Chacon M; Otorhinolaryngology Department, Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Alobid I; Otorhinolaryngology Department, Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Bernal-Sprekelsen M; Otorhinolaryngology Department, Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Puig S; Melanoma Unit, Department of Dermatology, Hospital Clinic de Barcelona, IDIBAPS, Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain.; Langdon C; Otorhinolaryngology Department, Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
Publisher: International Rhinologic Society Country of Publication: Netherlands NLM ID: 0347242 Publication Model: Print Cited Medium: Print ISSN: 0300-0729 (Print) Linking ISSN: 03000729 NLM ISO Abbreviation: Rhinology Subsets: MEDLINE
Academic Journal
Pires da Silva I; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia.; Westmead and Blacktown Hospitals, Sydney, Australia.; Ahmed T; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; McQuade JL; The University of Texas MD Anderson Cancer Center, Houston, TX.; Nebhan CA; Vanderbilt University Medical Center, Nashville, TN.; Park JJ; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.; Versluis JM; Netherlands Cancer Institute, Amsterdam, the Netherlands.; Serra-Bellver P; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Khan Y; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Slattery T; The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Oberoi HK; Hospital Clinic, Barcelona & IDIBAPS, Barcelona, Spain.; Ugurel S; University Hospital Essen, University of Duisburg-Essen, German Cancer Consortium, Partner Site Essen, Essen, Germany.; Haydu LE; Westmead and Blacktown Hospitals, Sydney, Australia.; Herbst R; Helios Klinikum Erfurt, Erfurt, Germany.; Utikal J; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.; Pföhler C; Saarland University Medical Center, Homburg/Saar, Germany.; Terheyden P; Department of Dermatology, University of Lübeck, Lübeck, Germany.; Weichenthal M; University Skin Cancer Center Kiel, University Hospital of Schleswig-Holstein, Kiel, Germany.; Gutzmer R; Skin Cancer Center, Department of Dermatology, Mühlenkreiskliniken, Ruhr University Bochum Campus Minden, Minden, Germany.; Mohr P; Elbe-Klinikum Buxtehude, Buxtehude, Germany.; Rai R; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Smith JL; Westmead and Blacktown Hospitals, Sydney, Australia.; Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Arance AM; Hospital Clinic, Barcelona & IDIBAPS, Barcelona, Spain.; Pickering L; The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Larkin J; The Royal Marsden NHS Foundation Trust, London, United Kingdom.; Lorigan P; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.; Blank CU; Netherlands Cancer Institute, Amsterdam, the Netherlands.; Schadendorf D; University Hospital Essen, University of Duisburg-Essen, German Cancer Consortium, Partner Site Essen, Essen, Germany.; Davies MA; The University of Texas MD Anderson Cancer Center, Houston, TX.; Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Westmead and Blacktown Hospitals, Sydney, Australia.; Johnson DB; Vanderbilt University Medical Center, Nashville, TN.; Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia.; Royal North Shore and Mater Hospitals, Sydney, Australia.; Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Royal North Shore and Mater Hospitals, Sydney, Australia.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Report
Boswell L; Endocrinology and Nutrition Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Institute of Biomedical Investigations August Pi Sunyer (IDIBAPS), Barcelona, Spain, Barcelona, Spain.; Endocrinology and Nutrition Department, Althaia University Health Network, Manresa, Spain.; Casals G; Institute of Biomedical Investigations August Pi Sunyer (IDIBAPS), Barcelona, Spain, Barcelona, Spain.; Biochemistry and Molecular Genetics Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Blanco J; Endocrinology and Nutrition Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Institute of Biomedical Investigations August Pi Sunyer (IDIBAPS), Barcelona, Spain, Barcelona, Spain.; Jiménez A; Endocrinology and Nutrition Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Institute of Biomedical Investigations August Pi Sunyer (IDIBAPS), Barcelona, Spain, Barcelona, Spain.; Centre of Obesity and Nutrition Biomedical Research Network (CIBEROBN), Carlos III Health Institute, Madrid, Spain.; University of Barcelona, Barcelona, Spain.; Aya F; Institute of Biomedical Investigations August Pi Sunyer (IDIBAPS), Barcelona, Spain, Barcelona, Spain.; Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; de Hollanda A; Endocrinology and Nutrition Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Institute of Biomedical Investigations August Pi Sunyer (IDIBAPS), Barcelona, Spain, Barcelona, Spain.; Centre of Obesity and Nutrition Biomedical Research Network (CIBEROBN), Carlos III Health Institute, Madrid, Spain.; Halperin I; Endocrinology and Nutrition Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Institute of Biomedical Investigations August Pi Sunyer (IDIBAPS), Barcelona, Spain, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Arance AM; Institute of Biomedical Investigations August Pi Sunyer (IDIBAPS), Barcelona, Spain, Barcelona, Spain.; Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Mora M; Endocrinology and Nutrition Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Institute of Biomedical Investigations August Pi Sunyer (IDIBAPS), Barcelona, Spain, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Centre of Diabetes and Related Metabolic Diseases Biomedical Research Network (CIBERDEM), Carlos III Health Institute, Madrid, Spain.; Hanzu FA; Endocrinology and Nutrition Department, Hospital Clínic of Barcelona, Barcelona, Spain.; Institute of Biomedical Investigations August Pi Sunyer (IDIBAPS), Barcelona, Spain, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Centre of Diabetes and Related Metabolic Diseases Biomedical Research Network (CIBERDEM), Carlos III Health Institute, Madrid, Spain.
Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2040-1124 (Electronic) Linking ISSN: 20401116 NLM ISO Abbreviation: J Diabetes Investig Subsets: MEDLINE
Academic Journal
Dalle S; Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, 69495, Pierre-Bénite, France. stephane.dalle@chu-lyon.fr.; Mortier L; Université de Lille, INSERM U1189, CHRU Lille, 59037, Lille, France.; Corrie P; Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB0 2QQ, UK.; Lotem M; Hadassah Hebrew University Hospital, 91120, Jerusalem, Israel.; Board R; Royal Preston Hospital, Preston, PR2 9HT, UK.; Arance AM; Hospital Clínic Barcelona, 08036, Barcelona, Spain.; Meiss F; Department of Dermatology, Faculty of Medicine, Medical Center - University of Freiburg, 79104, Freiburg, Germany.; Terheyden P; University of Lübeck, 23538, Lübeck, Germany.; Gutzmer R; Medizinische Hochschule Hannover, 30625, Hanover, Germany.; Buysse B; Syneos Health, Morrisville, NC, 27560, USA.; Oh K; Syneos Health, Morrisville, NC, 27560, USA.; Brokaw J; Bristol Myers Squibb, Princeton, NJ, 08543, USA.; Le TK; Bristol Myers Squibb, Princeton, NJ, 08543, USA.; Mathias SD; Health Outcomes Solutions, Winter Park, FL, 32790, USA.; Scotto J; Bristol Myers Squibb, Princeton, NJ, 08543, USA.; Lord-Bessen J; Bristol Myers Squibb, Princeton, NJ, 08543, USA.; Moshyk A; Bristol Myers Squibb, Princeton, NJ, 08543, USA.; Kotapati S; Bristol Myers Squibb, Princeton, NJ, 08543, USA.; Middleton MR; Churchill Hospital, Oxford, OX3 7DQ, UK.
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Arance, AM
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어